Method for Detection for Hydrosulfide Anion (HS-) and Hydrogen Sulfide (H2S)

Case ID:
UO-16-18
Web Published:
5/2/2022
Description:

1. Technology Overview 

The invention focuses on a new method for detecting hydrosulfide anion (HS⁻) and hydrogen sulfide (H₂S) using reversible, supramolecular binding interactions. This method utilizes non-covalent interactions, specifically hydrogen bonds, to detect HS⁻/H₂S without altering the analyte concentration. The technology is currently in the development stage, with promising cross-industry applications in biological detection, imaging, and targeted drug delivery. 

2. Key Features and Benefits 

  • Reversible Detection: Preserves analyte concentration during experimentation. 

  • Supramolecular Interactions: Utilizes hydrogen bonds for detection. 

  • Versatility: Applicable to various industries, including biotechnology and pharmaceuticals. 

  • Scalability: Synthesis processes can be scaled for larger quantities. 

  • Targeted Applications: Ideal for biological detection, imaging, and drug delivery systems. 

3. Applications and Market Focus 

  • Biological Detection: Use in detecting and imaging biological processes involving HS⁻/H₂S. 

  • Drug Delivery: Integration into targeted drug delivery systems. 

  • Biotechnology: Development of novel biological detection and imaging methods. 

  • Pharmaceutical Industry: Synthesis of complex organic molecules for various applications. 

  • Chemical Industry: Use in advanced synthesis techniques and equipment. 

4. Commercial Advantages 

  • Strategic Benefits: Provides reliable and scalable HS⁻/H₂S detection methods for various applications. 

  • Implementation Advantages: Facilitates integration into existing biological detection and imaging systems. 

  • Market Positioning: Positions technology as a key enabler for advanced biological detection and drug delivery systems. 

  • Competitive Advantages: Offers reversible detection and supramolecular interactions compared to existing methods. 

5. Partnership Opportunities 

  • Ideal Licensing Partners: Biotechnology firms, pharmaceutical companies, chemical industry leaders. 

  • Cross-Sector Partnership Benefits: Collaboration opportunities across biotechnology and pharmaceutical industries. 

  • Diverse Market Opportunities: Potential for global market expansion in regions with strong biotechnology and pharmaceutical industries. 

  • Collaborative Development: Opportunities for joint development of hybrid devices and custom synthesis services. 

Patent Information:
For Information, Contact:
Elliot Reed
Innovation Partners Director
University of Oregon
elliotr@uoregon.edu
Inventors:
Michael Haley
Darren Johnson
Michael Pluth
Ryan Hansen
Matt Hartle
Blakely Tresca
Keywords:
© 2026. All Rights Reserved. Powered by Inteum